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patients and those who had undergone adjuvant radiotherapy were significantly more likely to prefer that 
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in decision-making, having a surgeon explain treatment options in a clear, unhurried and open manner is 
vital to how patients feel about their treatment. Whilst acknowledging that individual patients will have 
different needs for information and preferences for treatment, there are several factors amongst many in 
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Abstract
Objectives To determine which aspects of the treatment decision
process, therapy and outcomes are most important to patients with
colorectal cancer (CRC).
Design Cross-sectional survey.
Participants A total of 102 men and 73 women who had completed
primary treatment for CRC in two teaching hospitals in Central
Sydney, Australia.
Main outcomes measures Patient’s rating of the importance of the
decision-making aspects and outcomes of treatment for CRC.
Results Trust in their surgeon and confidence of specialty training
are of paramount importance to CRC patients. Patients also have a
strong desire to get on with treatment quickly and rate the risk of
disease recurrence and quality of life as being very important in their
treatment decisions. Gender, age and whether the patient had
undergone adjuvant radiotherapy were all significant predictors of
preferred mode of treatment decision-making. Fifty-eight per cent of
women preferred a shared decision-making role compared with 36%
of men, whilst older patients and those who had undergone adjuvant
radiotherapy were significantly more likely to prefer that their
surgeon decide upon treatment when compared with younger
patients and respondents who have not had radiotherapy.
Conclusions Regardless of whether a patient prefers an active or
more passive role in decision-making, having a surgeon explain
treatment options in a clear, unhurried and open manner is vital to
how patients feel about their treatment. Whilst acknowledging that
individual patients will have different needs for information and
preferences for treatment, there are several factors amongst many in
the process of decision-making which are considered very important
by patients with CRC. A surgeon who adopts a consultation
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style that is open and informative, that offers patients the chance to
participate in the process of decision-making and clearly explain
treatment options and outcomes will engender trust with their patient.
Introduction
Trust between a patient and their doctor is
central to the care they receive. This relationship
of trust is forged in the clinical encounter where
crucial decisions about treatment are made and
which will ultimately influence the long-term
well-being of patients.1 There are many factors
that may influence, or impinge upon, the rela-
tionship between a patient and their doctor.
Perhaps none more so than the practice of evi-
dence-based medicine, multidisciplinary care
and patient involvement in making treatment
choices. Evidence-based surgery and patient
involvement in deciding between particular
treatment options in cancer surgery often
require balancing quality of life outcomes with
the chance of disease recurrence and survival
outcomes. The multidisciplinary nature of can-
cer treatment often involves differing combi-
nations of surgery, chemotherapy and
radiotherapy for different stages of disease and
this can make patient decision conflict a poten-
tial problem.2 This conflict occurs repetitively in
such common cancers as prostate, breast and
rectal.2 Together, these factors are driving a shift
from the traditional model of care based on
medical beneficence to the one more based on
individual patient autonomy. This shift has been
described as a move towards evidence-based
patient choice (EBPC).3 EBPC is relatively new
and, as Sheldon points out, there are difficulties
in conceptualizing and implementing it.4 But
essentially EBPC is a concept that captures
patients desire for evidence-based information
on treatment outcomes and the centrality of
individual patient choices and values in medical
decision-making. The central component of
EBPC is a respect for the autonomy of patients
to choose the role they would prefer in decision-
making and an entitlement to receiving care that
is based on evidence of what is known to be
effective and safe.5 That respect must come from
their health-care providers. If the components of
a good clinical encounter are in place, the out-
comes for patients are generally more positive.1
But as Dieppe argues, much work needs to be
done to explore which components of the clin-
ical encounter are of utmost importance.1,6
Henman et al.,6 in a qualitative study on lay
constructions of decision-making in cancer
found that personal factors were important to
women with breast cancer in their decision-
making. These included the feeling that the
doctor cared for, understood and respected
them; that they could trust and have confidence
in their doctor; that the doctor would give them
enough time, that they would be listened to; and
that the doctor would be open and honest. If
these factors were felt to be present, many
women were happy to accept the doctor’s
recommendation, confident that they would
receive optimum treatment. Yet other women
felt there was no decision to be made, they just
wanted to get on with their treatment.
In studies on patient preferences for colorectal
cancer (CRC), most have focused exclusively on
outcomes.7 Whilst the outcomes of treatment,
such as survival, side-effects and quality of life
are very important to patients, the process of
decision-making and their relationship with the
specialist is also important as to how they feel
about those outcomes in the long-term.8–10
In seeking the views of patients on treatment
decisions for CRC, this study explores the rel-
ative importance that patients attach to the
relationship with their surgeon, their involve-
ment in decision-making and aspects of their
treatment and outcomes.
Methods
The study was conducted in two stages. The first
stage consisted of an interview-based qualitative
study with 13 CRC patients. The interviews were
used to address the relatively unexplored area of
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patients own constructions and explanations of
how they made decisions about treatment for
CRC (paper in preparation). The main themes
to emerge from the qualitative data were: the
role of the surgeon, the decision-making process,
patient support, the type of treatment and the
outcomes of treatment. In the second stage, the
results of the qualitative research were used to
construct a self-administered questionnaire in
which patients were asked to rate the importance
of aspects of the treatment decision process and
outcomes.
Sampling and recruitment
Participants were recruited from five colorectal
surgeons who operate at two major teaching
hospitals in Sydney, Australia. Eligible patients
had a diagnosis of cancer of the colon or rec-
tum, were a minimum of 6 months and maxi-
mum of 2 years post-resection, had completed
any adjuvant therapy and were not undergoing
any treatment or palliation, had no recurrence
of disease and were English speaking. The
sampling frame was based on a CRC database
at each of the two hospitals. All eligible
patients were contacted by telephone to explain
the purpose of the study and obtain their
consent to receive a questionnaire, with a cov-
ering letter from their surgeon. Mail details
were confirmed for those consenting to parti-
cipate. Follow-up strategies were instituted for
non-participants.11
Measures
Patients views on the treatment decision
process, treatment and outcomes
Patients views on the importance of aspects of
the treatment decision process and outcomes
were assessed by 38 questions that covered the
range of issues identified in the qualitative
research. Participants were asked to complete a
self-administered questionnaire which was con-
structed in three parts. The first section asked
patients whether or not a family member or
friend had had CRC and, if so, their relation-
ship to that person. The second section con-
sisted of 22 Likert scale questions in which
participants were asked to rate the importance
of aspects of the decision-making process
(1 ¼ very important to 5 ¼ not important at
all). The third section consisted of 17 Likert
scale questions in which participants were
asked to rate the importance of aspects of the
outcomes of treatment. Participants were also
asked to select one of the five responses to a
question assessing preferences for involvement
in decision-making, adapted from a study by
Degner et al.12
Demographics
Demographic details on the patient’s age, gen-
der, highest educational qualification achieved,
occupation, marital status, years living in
neighbourhood, stage of cancer, adjuvant ther-
apy received, family member or friend with
CRC, were requested from participants.
Statistical analysis
Descriptive analysis was conducted on all
responses using the Statistical Package for Social
Sciences (SPSS).13 Likert responses were dicho-
tomized into important (very import-
ant + important) or neutral/unimportant
(neither important nor unimportant + not
important at all + not so important) in order to
conduct tests of association between sociode-
mographic variables and response variables.
These tests were carried out using the Pearson v2
statistic. A higher level of statistical significance,
P < 0.01, was set because of the multiple
number of tests carried out.
Principal component analysis was conducted
on the continuous data responses to 22 Likert
questions on the treatment decision process and
separately on responses to 17 Likert questions
on the outcomes of treatment for 175 CRC
patients. The purpose of this analysis is to
identify a smaller number of components of the
treatment decision process and outcomes of
treatment based on the responses to the 39
individual questions. As interpretation of the
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components is in terms of the original variables,
we used component correlations, or loadings,
>0.5 to indicate those variables with which a
component is correlated. This, in turn, provides
a guide to the interpretation of that component.
Both the eigenvalue greater than one criterion
and the screen test were used to determine the
number of components extracted, because the
simple eigenvalue greater than one rule can
sometimes lead to over-factoring.14,15 The
components were rotated to an orthogonal,
Varimax simple structure solution.
A forward stepwise logistic regression was
conducted with the preferred decision-making
response as the dependent variable, dichotom-
ized into surgeon decides (surgeon alone
decides + surgeon decide after taking my
opinion into account) and shared decision-
making (all remaining categories) and inde-
pendent variables including age, sex, employ-
ment status and adjuvant therapy.
Results
A total of 220 patients were eligible for inclu-
sion in the study of whom 207 (94%) agreed to
participate in the study and 175 questionnaires
were returned (80% response rate). Demogra-
phic and clinical characteristics of participants,
by gender, are presented in Table 1. Treatment
differences between men and women reflect the
age distribution and the slightly higher number
of rectal cancers amongst the male participants.
Importance of aspects of the treatment
decision process
The importance of each of the 22 aspects of the
treatment decision process is summarized in
Table 2, with the responses grouped according
to the results of the principal component ana-
lysis. From this analysis, five factors were
identified on the treatment decision process.
The five factors were identified as trust in sur-
geon (F1), emotional support (F2), health ser-
vices and referral (F3), information and
communication (F4) and clinical care (F5).
Factor 1, trust, accounts for 14.8% of the total
variation in the 22 variables. Trust is based on
the patient’s perception of the surgeon’s tech-
nical competency, the surgeon’s openness,
ability to talk to the patient in plain language
and to listen to what the patient has to say.
Factor 2, emotional support, accounts for
11.7% of the total variation and is based on
whether a patient feels supported in their
decision-making by their GP, family, friends
and other CRC patients. Factor 3, health ser-
vices and referral accounts for 9.25% of the
total variation. This component reflects a
patient’s desire to get treatment as quickly as
possible where the surgeon considers their
needs and keeps their GP informed of their
treatment. Factor 4, information and commu-
nication, accounts for 9.25% of the total vari-
ation. It represents the surgeon’s ability to
explain all the treatment options, to provide
written information on treatment and the
patient’s ability to get information from other
sources (including a second opinion if desired).
Factor 5, clinical care, accounts for 8% of the
total variation. This component reflects the
importance of the surgeon’s specialization in
CRC and the availability of a CRC patient
support group. Together, the five components
account for 53% of the variability in responses.
Relationship between the importance
of the treatment decision process
and specific patient characteristics
Three characteristics of participants, highest
level of education obtained, employment status
and marital status were associated with the
importance that patients attached to the treat-
ment decision process. Thirty-five per cent of
participants who had completed a trade or
higher education qualification thought it was
important to let the family have a say about
their treatment compared with 56% of partici-
pants who had not completed this level of edu-
cation (v2 ¼ 1 4.1, 4 d.f., P ¼ 0.007). Nineteen
per cent of participants who were employed, a
student or had retired from work, thought it was
important to listen to what friends had to say
about their treatment compared with 48% of
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participants who were employed in home duties,
unemployed or unable to work (v2 ¼ 8.9, 1 d.f.,
P ¼ 0.003).
Importance of aspects of the outcomes
of treatment
The importance of each of the 17 aspects of
treatment and outcomes is summarized in
Table 3, with the responses grouped according
to the results of a second principal component
analysis. In this analysis, four factors were
identified on the outcomes of treatment,
accounting for 63% of the variance. The four
factors were identified as getting on with life
(F1), adjuvant therapy and side-effects (F2),
type of surgical procedure (F3), and disease
recurrence and quality of life (F4; 11.3% of
variance). Factor 1, getting on with life,
accounts for 19.7% of the total variation in the
Table 1 Demographic and clinical
characteristics of the respondents,
by gender
Men (n ¼ 102)
n (%)
Women n ¼ 73
n (%)
Total n ¼ 175
n (%)
Age group
£50 years 9 (9) 9 (13) 18 (11)
51–64 years 29 (29) 20 (28) 49 (29)
65–74 years 33 (33) 17 (24) 50 (29)
75 years+ 29 (29) 26 (36) 55 (32)
Highest level of education
Did not complete secondary school 39 (39) 29 (40) 68 (40)
Completed secondary school 16 (16) 22 (31) 38 (22)
Trade or technical qualification 26 (26) 10 (14) 36 (21)
University or college 19 (19) 10 (14) 29 (17)
Employment status
Employed or student 23 (23) 14 (19) 37 (22)
Not employed 77 (77) 58 (81) 135 (78)
Marital status
Married 81 (83) 36 (49) 117 (68)
Other 17 (17) 37 (51) 54 (32)
Years living in neighbourhood
<5 years 15 (15) 12 (17) 27 (16)
Between 5 and 10 years 10 (10) 14 (20) 24 (14)
Between 10 and 20 years 13 (13) 8 (11) 21 (12)
More than 20 years 63 (62) 37 (52) 100 (58)
Treatment – chemotherapy
Yes 28 (28) 11 (16) 39 (23)
No 71 (72) 60 (85) 131 (77)
Radiotherapy
Yes 15 (15) 4 (6) 19 (11)
No 84 (85) 68 (94) 152 (89)
A family member has ever had bowel cancer
Yes 28 (28) 28 (39) 56 (33)
No 57 (57) 38 (53) 95 (55)
Do not know 15 (15) 6 (8) 72 (172)
A friend has ever had bowel cancer
Yes 45 (45) 19 (26) 64 (37)
No 46 (46) 40 (55) 86 (50)
Do not know 9 (9) 13 (18) 22 (13)
Stage of cancer at diagnosis
Dukes stage A 52 (54) 46 (66) 98 (59)
Dukes stage B 26 (27) 15 (21) 41 (25)
Dukes stage C 17 (18) 9 (13) 26 (16)
Where data are missing, columns do not add up to n.
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17 variables. Factor 2, adjuvant therapy and
side-effects accounts for 16.9% of variance.
This component is based on the desire to
minimize pain and regret associated with
treatment, a general desire to avoid adjuvant
therapy if possible and to minimize the side-
effects of treatment. Factor 3, type of surgical
procedure, accounts for 15.4% of variance and
is based on a patient’s desire to avoid a big
operation and/or the need for a colostomy bag.
Factor 4, disease recurrence and quality of life,
accounts for 11.3% of variance. This compo-
nent reflects a patient’s desire to minimize the
chance of a disease recurrence and to return to
a normal quality of life. Together, the four
components account for 63% of the variability
in responses.
Relationship between the importance
of the treatment decision process
and specific patient characteristics
Three characteristics of participants, a family
member with CRC, whether the patient had
undergone adjuvant therapy and highest level of
education obtained were associated with the
importance that patients attached to the out-
comes of treatment. These results are summarized
in Table 42 .
Table 2 Respondents’ rating of the importance of aspects when choosing treatment for colorectal cancer






Based on your experience, what do you think are
the important aspects when choosing any treatment
for colorectal cancer?
F1. Surgeon – trust
Have surgeon who is up-to-date with treatment options 100 –
Have the surgeon explain the treatment in a straight-forward manner 99 1
Have the surgeon be open about the patient’s condition and prognosis 99 1
Have the surgeon give plenty of time and not hurry the consultation 98 1
Have a lot of support from the family 96 2
Have the surgeon listen to what the patient has to say 94 3
F2. Emotional support
Have my GP help with treatment decisions 56 21
Hear about the experience of someone who has had colorectal cancer 55 20
Let the family have a say about treatment 42 24
Listen to what friends have to say about the treatment 22 24
F3. Health Services & referral
Have surgery as soon as possible 98 2
Surgeon considers patient’s needs 98 2
Medical specialists keeping GP informed 90 8
Be referred to a surgeon by someone the patient trusts 89 9
Referred to a surgeon who operates at a teaching hospital 68 21
F4. Information and communication
All treatment options are explained 94 4
Receive written information on the treatment options 78 7
Get as much information from as many sources as possible 66 18
Take time to think about treatment decisions before commencing trt 62 15
Get a second opinion 46 30
F5. Clinical care
Surgeon only treatments colorectal cancer disorders 95 3
Have a colorectal cancer patient support group available 63 2
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Preferred mode of decision-making
Participants preferred mode of decision-
making is summarized in Table 5. The results
of the logistic regression analysis showed that
gender, age and whether the patient had had
radiotherapy were significantly associated with
their preferred decision-making role (Table 6).
Women are 2.6 times more likely than men to
choose a shared decision role whilst patients
who have undergone adjuvant radiotherapy are
80% less likely to prefer a shared decision role
with their surgeon compared with those who
have not had radiotherapy. Age is negatively
related to preferred decision-making role, which
means older patients are more likely to prefer
the surgeon to decide their treatment. A
patients employment status, their surgeon,
stage of cancer and level of education were not
statistically significant predictors of decision-
making role.
Discussion
From the patient’s point of view, establishing
trust in their surgeon was very important and was
crucial in accepting that the right treatment
decisions were being made. Trust was built on
confidence in the expertise of their surgeon and a
belief that their doctor was genuinely concerned
about them. Henman et al.,6 in a qualitative
study of lay constructions of decision-making
found that genuine concern was seen in giving
adequate time for a consultation, being listened
to, having questions answered and the doctor
having a caring and empathetic attitude. We
found that all these factors associated with the
process of the consultation were very important
for the participants in this study. Confidence was
also based on the patients perception that their
surgeon had specialist knowledge and training in
CRC, was up-to-date with treatment options and
was prepared to listen to what the patient had to
Table 3 Respondents’ rating of the importance of aspects of the outcomes of treatment






It is important to choose a treatment which would:
F1. Getting on with life
Get everything done as quickly as possible to get on with life 78 11
Minimize any disruption to the patient’s lifestyle while having treatment 65 14
Keep the family happy 51 19
Get the patient back to work as quickly as possible 49 22
Minimize the cost of having treatment 48 21
Ensure that business/work was minimally affected 36 24
F2. Adjuvant therapy and side effects of treatment
Leave no feelings of regret 88 5
Minimize pain during treatment 83 8
Avoid the unpleasant side-effects of the treatment,
such as nausea, diarrhoea and dry mouth
70 14
Avoid having chemotherapy 57 20
Avoid having radiotherapy 57 20
F3. Type of surgical procedure
Avoid having a permanent colostomy bag 82 8
Avoid having a temporary colostomy bag 58 16
Avoid a big operation 55 22
F4. Recurrence of CRC and quality of life
Reduce the risk of the colorectal cancer coming back 100 –
Result in a normal quality of life after the treatment has finished 100 –
Avoid any long-term pain as a result of treatment 97 1
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say. For some, confidence was enhanced by more
active participation in decision-making with their
surgeon. Fallowfield and colleagues studied 269
women with early stage breast cancer from the
time of diagnosis for 3 years.16,17 The authors
concluded that the consultation style of surgeons
is more important for psychological well-being
than being allowed choice of treatments. That is,
being a participant in decision-making is more
critical for patient well-being than actually
determining the direction of their care. What is it
about decision-making that is important to
patients?
A recent qualitative study on decision-making
in cancer found that even when patients report a
desire for collaborative decision-making, they
rely heavily on their doctor’s opinion and seek
rather to understand the rationale behind the
doctor’s recommendation than to make the
decision themselves.6 Having a surgeon explain
treatment options in a clear, unhurried and open
manner was important or very important to
Table 4 Relationship between the
importance of the treatment decision






or ‘important’) v2 P-value
Family member has colorectal cancer
Avoiding side-effects of treatment
Yes 80 18.5 (2 d.f.) <0
No 67
Do not know 33
Patient has had chemotherapy
Avoiding chemotherapy
Yes 25 20.86 (1 d.f.) <0
No 67
Patient has had chemotherapy
Avoiding radiotherapy
Yes 34 10.8 (1 d.f.) 0.001
No 65
Patient has had radiotherapy
Have trt quickly and get on with life
Yes 56 6.5 (1 d.f.) 0.01
No 82
Highest level of education
Avoiding side-effects of treatment
Did not complete secondary 85 14.7 (3 d.f.) 0.005
Completed secondary school 62
Trade or technical qualification 63
University or college 53
Highest level of education
Avoiding a very big operation
Did not complete secondary 73 15.0 (3 d.f.) 0.005
Completed secondary school 44
Trade or technical qualification 40
University or college 43
Highest level of education
Minimize pain during treatment
Did not complete secondary 94 16.9 (3 d.f.) 0.002
Completed secondary school 84
Trade or technical qualification 83
University or college 60
Decision-making in colorectal cancer,1 G Salkeld et al.
 Blackwell Publishing Ltd 2004 Health Expectations, 7, pp.104–114
111
98% of our study participants. At the same time,
patients wanted the surgery as quickly as poss-
ible and less than half wanted a second opinion.
This is consistent with qualitative studies in
which patients say that they are afraid to take up
too much of their specialist’s time. Only 56% of
respondents wanted their GP to help with the
treatment decision.
Seeking to understand treatment is important
for both men and women, regardless of whe-
ther they preferred an active or more passive
role in decision-making. Yet, women do prefer
to take a more active role in the decision-
making process. A recent study on women’s
decision-making preferences for breast cancer
screening and treatment found that 91% pre-
ferred to share decision-making equally with
their doctor or to take a more active role.18
This is consistent with other studies on patient
preferences for breast cancer treatment. Men
appear to be more willing to allow some degree
of paternalism in decision-making (with over
60% of men in our sample wanting the surgeon
to decide) as do older patients. Both gender
and age were significantly associated with a
preference for the surgeon to decide treatment.
Leydon et al.19 in their study of cancer patient’s
information needs found that older patients
and men are more likely to adopt a non-
participatory role in the management of their
illness. Men maintained a sense of hope (for
survival) through silence and, more generally,
through strength of silence and this influenced
their desire for more information and avoid-
ance of new information.19
Making treatment choices that would leave
no feelings of regret was rated as important or
very important by 88% of participants. In a
study by Clark et al.20 on treatment decisions
for men with metastatic prostate cancer, regret
was strongly associated with poor quality of life
and was negatively associated with satisfaction
with both treatment choice and decision-
making role. The more regret felt by a patient
the less satisfied they were with the outcome of
treatment. Other studies have found a clear
association between decision-making role and
psychological well-being. Gattelari et al.7 in a
study on sharing decisions in cancer, followed
233 patients before and after their treatment
consultation and measured the impact of
shared decision-making and the achievement
of preferred role on patient anxiety, recall of
information and satisfaction. The authors
found that failure to achieve preferred decision-
making roles adversely affected patient emo-
tional well-being, particularly anxiety levels.
Specifically, less involvement than preferred
appears more detrimental than involving
patients to a greater degree than preferred.
This finding suggests that it is better to provide
the opportunity for including the patient in
decision-making during the consultation and to
respect their input even where a patient expects
the surgeon to make the final decision.












I decide 2 (2) 1 (1) 3 (2)
Myself but consider
surgeon’s opinion
10 (10) 14 (20) 24 (14)
Surgeon and I share 24 (24) 26 (37) 50 (29)
My surgeon decides
but considers my opinion
33 (33) 16 (23) 49 (29)
My surgeon decides 32 (32) 13 (19) 45 (26)
Where data are missing, columns do not add up to n.







Female 0.961 0.338 2.62 (1.35–5.1)
Whether the patient had adjuvant radiotherapy
No 1
Yes )1.642 0.691 0.194 (0.050–0.75)
Age
(continuous variable)
)0.40 0.014 0.961 (0.934–0.989)
*Outcome variable 0 ¼ surgeon decides; 1 ¼ shared decision-making
role.
Reference category.
Decision-making in colorectal cancer,1 G Salkeld et al.
 Blackwell Publishing Ltd 2004 Health Expectations, 7, pp.104–114
112
Within the sampling frame, there were 14
patients who were undergoing treatment or
palliation and four patients who were non-
English speaking. In accordance with the
eligibility criteria, these patients were not
approached to participate in the study. The
views of patients undergoing treatment or
palliation may have been different from the
eligible group by virtue of their circumstances.
Opinions may be influenced by the immediacy
of the need to undergo treatment or palliation
and the desire to get back to health. More
generally, a key question is whether patient
opinions about decision-making are likely to
change over time.
We knew from the qualitative research in
stage 1 that survival was the highest priority for
most patients. A typical comment on surviving
their cancer was
…your priorities, what you were weighing up?
…Stay alive, that is all I thought about …you have
got to survive.
This is consistent with the findings of Little
et al.21 where CRC patients expressed the view
that they wanted the best chance of survival (this
was assumed knowledge) and Beaver et al.8
where CRC patients ranked cure as the most
important factor to them. Beyond the immediate
desire for survival lay concerns about their long-
term quality of life and the chance of the CRC
coming back. Both these factors were rated as
important by all the participants in this study.
However, the means by which they achieved
these outcomes also mattered. There was a very
clear sociodemographic gradient in the percep-
tion of patients on the impact of treatment on
their health. Participants who had not comple-
ted primary or high school thought it was more
important to avoid having a big operation, to
avoid the side-effects of treatment and to min-
imize pain during treatment compared with
more highly educated patients. The results do
not provide any insight as to why this might be
the case. It is possible that the provision of more
information on managing pain and side-effects
would change the individuals perception of the
importance of these factors.
It is not surprising that the views of patients
who had undergone adjuvant therapy were sys-
tematically different from those who had not. In
two separate studies, Henman et al.6 and
Charles et al.22 found that by accepting adjuvant
treatment, women could reassure themselves
that they had done everything possible to max-
imize the chances of avoiding disease recurrence.
Hence women felt that avoiding adjuvant ther-
apy was simply out of the question. Once having
survived a difficult experience, most people
become more strongly convinced of the cor-
rectness of their decision to undergo it because
the alternative (that adjuvant therapy was all for
nothing) is too distressing. Nonetheless, 25% of
patients who had chemotherapy thought it was
important to avoid having adjuvant therapy,
suggesting an element of regret. Further research
is needed to determine which factors (such as
quality of life) have the most influence on a
decision to have adjuvant therapy and on
experiencing regret afterwards.
The principal component analysis reduced the
22 items on the decision-making process down
to five components and the 17 items on the
outcomes of treatment down to four compo-
nents. We suggest that these nine components
are qualitatively generalizable to other CRC
surgical settings. For the sake of wider general-
izability, other researchers wishing to explore
decision-making in CRC might use these nine
components as the basis of further study in this
area.
Conclusion
Whilst acknowledging that individual patients
will have different needs for information and
preferences for treatment, there are several fac-
tors amongst many in the process of decision-
making which are considered very important by
patients with CRC. A surgeon who adopts a
consultation style that is open and informative,
that offers patients the chance to participate in
the process of decision-making and clearly
explain treatment options and outcomes will
engender trust with their patient.
Decision-making in colorectal cancer,1 G Salkeld et al.
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